Foundation Consumer Healthcare, LLC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Foundation Consumer Healthcare, LLC - overview

Established

2014

Location

Pittsburgh, PA, US

Primary Industry

Pharmaceuticals

About

Foundation Consumer Healthcare, based in the US, specializes in the development and manufacturing of over-the-counter healthcare products to enhance consumer well-being, focusing on accessibility and convenience in health solutions. Foundation Consumer Healthcare, established in 2014 and headquartered in Pittsburgh, US, is dedicated to the production of essential OTC healthcare products. The company was acquired by Kelso & Company in November 2017, with financial terms undisclosed. The current CEO is Gregory Bradley.


Foundation Consumer Healthcare focuses on the development and manufacturing of a diverse portfolio of over-the-counter (OTC) healthcare products designed to enhance consumer well-being. Their core product offerings include emergency contraception, particularly the Plan B One-Step® 1. 5 mg levonorgestrel, which serves to prevent pregnancy after unprotected intercourse and has been pivotal in providing consumers with timely reproductive health solutions. These products cater to a broad client base, including retailers, healthcare providers, and directly to consumers, ensuring accessibility and convenience of use.


Foundation Consumer Healthcare's products are distributed across various geographical markets, including but not limited to the United States, where they aim to address the urgent needs of consumers seeking accessible healthcare solutions. Foundation Consumer Healthcare generates revenue primarily through partnerships with retailers and wholesalers, who distribute their products to end consumers. Transactions typically occur on a B2B basis, where retailers purchase large quantities of products for resale, ensuring that the end users have ready access to these essential OTC healthcare items. Their flagship product, Plan B One-Step®, is a key driver of their revenue model, with pricing structures aligned with industry standards for similar OTC products.


The company capitalizes on strategic partnerships to expand market reach and increase product availability, thereby enhancing overall sales performance and customer engagement in the healthcare segment. Looking ahead, Foundation Consumer Healthcare intends to launch new products aimed at addressing diverse healthcare needs, with specific timelines and product details yet to be disclosed. The company is exploring expansion into new geographic markets beyond the United States, although targeted regions and dates for this expansion are currently unspecified. The acquisition by Kelso & Company in November 2017 will likely support these growth initiatives, providing necessary resources for product development and market penetration.


Current Investors

Juggernaut Capital Partners, Kelso & Company

Primary Industry

Pharmaceuticals

Sub Industries

Health Foods & Nutritional Supplements, Pharmaceutical Research & Development

Website

www.foundationch.com

Verticals

Manufacturing

Total Amount Raised

Subscriber access only

Foundation Consumer Healthcare, LLC - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedPlan B One-Step-
Add-onCompletedTake Action-
Add-onCompletedAftera-
Add-onCompletedNext Choice One Dose-
Secondary BuyoutCompletedFoundation Consumer Healthcare, LLC-

Displaying 1 - 5 of 7

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.